Drug Trial Radar · NCT01191840
Treatment Algorithm to Reduce the Use of Vancomycin in Adults With Blood Stream Infection
Last checked: Nov 19, 2026Latest source record: Jan 5, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
509
Actual
Start
Feb 2011
Primary completion
Mar 4, 2017
Study completion Mar 4, 2017
Sponsor
- Lead sponsor
- Duke UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- National Institutes of Health (NIH)
- First posted
- Aug 31, 2010
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to accurately determine the length of appropriate drug treatment for staphylococcal blood stream infection. The study seeks to address important information about the management of staphylococcal blood stream infections.
Conditions
- Bacteremia
Interventions
VancomycinDrug
Duration
VancomycinDrug
Duration
Primary outcomes
What the sponsor says the trial is designed to measure.
- Cure RateTime frame: Test of cure 2 (up to approximately 42 days)
- Number of Participants With Serious Adverse EventsTime frame: Test of cure 2 (up to approximately 42 days)
- Number of Participants With Adverse Events Leading to Study Drug WithdrawalTime frame: Test of cure 2 (up to approximately 42 days)
- Number of Participants That Changed From Vancomycin to Another Study Antibiotic Due to an Adverse EventTime frame: Test of cure 2 (up to approximately 42 days)
Locations
15 sites in 2 countries. Site status is shown where the registry gives one.
University of Alabama, Birmingham
Birmingham, Alabama
David Geffen School of Medicine UCLA
Los Angeles, California
University of Colorado
Denver, Colorado
University of Mass
Worcester, Massachusetts
Henry Ford Hospital
Detroit, Michigan
William Beaumont Hospital
Royal Oak, Michigan
University of Nebraska Medical Center
Omaha, Nebraska
Albert Einstein College of Medicine
The Bronx, New York
Carolina Medical Center
Charlotte, North Carolina
Duke University Medical Center
Durham, North Carolina
Brody School of Medicine at ECU
Greenville, North Carolina
Medical University of South Carolina
Charleston, South Carolina
Greenville Hospital System
Greenville, South Carolina
UT MD Anderson Cancer Center
Houston, Texas
Fundacio Clinic Privada per a la Recera
Barcelona, Spain
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.